Skip to search formSkip to main contentSkip to account menu

IMC C225

Known as: IMC-C225, C225 monoclonal antibody, monoclonal antibody C225 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

cetuximab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles.
Shortwave (MHz range) radiofrequency (RF) energy is nonionizing, penetrates deeply into biologic tissues with no adverse side… 
Review
2006
Review
2006
Dual immunoregulatory pathways of 4-1BB signaling
It is perhaps rare to encounter among the various immunologically competent receptor–ligand pairs that a single cell surface… 
Highly Cited
2005
Highly Cited
2005
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Highly Cited
2004
Highly Cited
2004
Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V.
UNLABELLED 99mTc-Labeled annexin V has been used for the imaging of tumor apoptosis induced by chemotherapy. However, owing to… 
2004
2004
Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptor
Drugs that inhibit the epidermal growth factor receptor, such as ZD1839 or C225, are being used increasingly in the treatment of… 
Review
2003
Review
2003
The epidermal growth factor receptor pathway and its inhibition as anticancer therapy.
Epidermal growth factor receptor (EGFR) is commonly overexpressed in a number of epithelial malignancies and is often associated… 
Highly Cited
2003
Highly Cited
2003
Patterns of MUC1 Tissue Expression Defined by an Anti-MUC1 Cytoplasmic Tail Monoclonal Antibody in Breast Cancer
Our aim was to determine the pattern of expression of MUC1 mucin cytoplasmic tail (MUC1 CT) in breast carcinoma. A total of 98… 
Highly Cited
2001
Highly Cited
2001
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
1995
1995
TOLERANCE INDUCTION IN A FULLY ALLOGENEIC COMBINATION USING ANTI‐T CELL RECEPTOR-αβ MONOCLONAL ANTIBODY, LOW DOSE IRRADIATION, AND DONOR BONE MARROW TRANSFUSION
In a murine strain combination disparate in both H-2 antigens and minor histocompatibility antigens consisting of C57BL/6 (B6; H… 
Highly Cited
1988
Highly Cited
1988
Monoclonal antibodies against different epitopes on colonization factor antigen I of enterotoxin-producing Escherichia coli
Hybridoma-secreting monoclonal antibodies (MAbs) against colonization factor antigen I (CFA/I) were produced by the fusion of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)